Initial Study Visit: Visit 1 will be scheduled for 8 weeks after birth (> 52 days and < 60 days). Blood will be drawn (sera 1) immediately prior to administration of the first dose of IPV and other recommended vaccines. Mother will be reminded of infant’s next appointment in 8 weeks.